Fundraising Fox
4see Ventures
Venture capitalChêne-Bougeries · Pre-Seed–Series A · 2 people tracked
Find your way into 4see Ventures
Sign up to see every warm intro you have to 4see Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 4see Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
4see ventures invests in emerging leaders across climatech, sustainability, and healthcare, aiming to help build game-changing companies globally. Its current investment focus is on Swiss early-stage startups in climatech and sustainability. The firm backs founders defined by a strong passion for their mission and a dedication to hard work, seeking entrepreneurs with the ambition to change the world, a clear vision to disrupt markets, and executable plans to bring that vision to life. The name reflects a philosophy of foresight — anticipating market developments, patterns, and trends before they fully unfold.
Source: firm website, verified Aug 7, 2026.
Team · 2 people
from the firm's website & public directories
What they invest in
from 7 of 9 portfolio companiesHealthtech ×3AI & Machine Learning ×2Biotech ×2Deep Tech ×2Medical Devices ×2Circular Economy ×1Construction Tech ×1Cybersecurity ×1
HQs:Switzerland×5
Investments · 9 tracked
founders shown can be your intro pathPartnerDaniel Bertholet· solo GP
Co-investorsBlockchain Valley Ventures, LlcCapDecisif ManagementKaristaKickstart Innovation
Distalmotion develops DEXTER, a surgical robotics system for minimally invasive procedures such as hernia repair, cholecystectomy, and hysterectomy, used by surgeons and clinical teams.
HealthtechMedical DevicesRoboticsLausanne, CH
PartnerDaniel Bertholet· solo GP
Co-investors415 CapitalPrivilège VenturesZühlke VenturesBlueOcean Ventures
FenX develops proprietary materials technology for sustainable, circular construction, aiming to produce affordable living spaces that reduce waste and improve energy efficiency.
Circular EconomyConstruction TechNew MaterialsZurich, CH
Dr. Alessandro Dutto(Co-founder, Formulation)Enrico Scoccimarro(CSO & Co-founder)inDr. Etienne Jeoffroy(CEO & Co-founder)Jens Diebold(COO)
PartnerDaniel Bertholet· solo GP
Co-investorsSupernova InvestMove Energy
Goodwall is a free social education app and B Corp that uses behavioral psychology and gamified design to teach young people future-ready skills.
EdTechFuture of WorkImpact & Social GoodSocialGeneva, CH
PartnerDaniel Bertholet· solo GP
Co-investorsCircle VenturesSICTIC
HAYA Therapeutics develops precision RNA medicines that target long non-coding RNAs (lncRNAs) in the regulatory genome to reprogram disease at the level of cell state, with a lead program in cardiac fibrosis and work in obesity and metabolic disease.
AI & Machine LearningBiotechDeep TechHealthtech
Samir Ounzain(Chief Executive Officer (CEO) & Co-founder)inDaniel Blessing(Chief Scientific Officer (CSO) & Co-founder)inRichard Law(Chief Business Officer (CBO))inEric Adam(Chief Operating Officer (COO))inJordan Shin(Chief Medical Officer (CMO))inJérôme Andries(Chief Financial Officer (CFO))in
PartnerDaniel Bertholet· solo GP
Co-investorsBroadview VenturesSofinnova PartnersApollo Health Ventures+ND CapitalLifelinkHumboldt
NetGuardians provides financial crime prevention intelligence software for detecting and preventing fraud, money laundering, and insider risk across banking institutions.
AI & Machine LearningCybersecurityFintechZurich, CH
PartnerDaniel Bertholet· solo GP
Co-investorsPolytech Ecosystem VenturesR136 VenturesACE & CompanyFort Ross VenturesPictet GroupSwisscom Ventures
Priothera is a clinical-stage biotech developing mocravimod (an S1P receptor modulator) for hematologic malignancies such as acute myeloid leukemia.
BiotechHealthtech
Florent Gros(Chief Executive Officer and Founder)Stephan Oehen(Chief Operating Officer and Founder)inBrice Suire(Chief Financial Officer and Founder)Nigel Clark(Chief Business Officer)Jens Hasskarl(Chief Medical Officer)
PartnerDaniel Bertholet· solo GP
Co-investorsFountain Healthcare PartnersHealthCap
Transmutex develops accelerator-powered technology that converts nuclear waste into clean energy and produces medical radioisotopes.
Deep TechEnergyMedical DevicesVernier (Geneva), CH
Franklin Servan-Schreiber(Founder & CEO)in
PartnerDaniel Bertholet· solo GP
Co-investorsAlleyCorpAt One VenturesHCVCSteel AtlasUnion Square Ventures (USV)Verve Ventures+4 more
.jpeg){kind=logo}
Portfolio news
latest coverage across their companiesFrequently asked questions
- How many investments has 4see Ventures made?
- 4see Ventures has 9 tracked investments, including 1 dated in the last 24 months.
- What stage does 4see Ventures invest at?
- 4see Ventures invests at the Pre-Seed, Seed, Series A stages.
- What is 4see Ventures's typical check size?
- 4see Ventures typically writes checks of $432K – $1.1M.
- What sectors does 4see Ventures focus on?
- 4see Ventures focuses on Biotech, Cleantech, Climate Tech, Consumer, Data & Infrastructure, Energy, Enterprise Software, Fintech, FoodTech, Healthtech, Impact & Social Good, Medical Devices, Robotics, SaaS.
- Where is 4see Ventures located?
- 4see Ventures is headquartered in Chêne-Bougeries, CH.
- Who does 4see Ventures co-invest with?
- 4see Ventures most often shares deals with AlleyCorp, At One Ventures, Blockchain Valley Ventures, Llc, among 28 tracked co-investors.
Co-investors · 3
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
Forbion is a global venture capital firm focused on advancing biotech innovations and other sustainable solutions aimed at improving human and planetary health.
New Leaf Venture Partners is a venture capital firm investing in innovative healthcare companies.
Firms observed investing alongside 4see Ventures, from public investor directories. Shared companies are the overlap with 4see Ventures's recorded portfolio.
Similar investors
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
Vespucci Partners is a venture capital firm that emphasizes sustainability and ESG principles across its portfolio, seeking startups and investments aligned with responsible, environmentally and socially conscious business practices.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Old College Capital (OCC) is the University of Edinburgh's venture investment fund, managing the University's early-stage investment activities and shareholdings. It is part of Edinburgh Innovations, the University's commercialisation service.
Artesian is a deep tech and hardware venture capital investor that builds funds around specific institutional backers — governments, corporations, universities, industry bodies and super funds — to pursue both financial returns and strategic outcomes in critical industries.